Matthew C Exline
Overview
Explore the profile of Matthew C Exline including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
3896
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Surie D, Yuengling K, DeCuir J, Zhu Y, Lauring A, Gaglani M, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e244954.
PMID: 38573635
Importance: On June 21, 2023, the Centers for Disease Control and Prevention recommended the first respiratory syncytial virus (RSV) vaccines for adults aged 60 years and older using shared clinical...
12.
DeCuir J, Payne A, Self W, Rowley E, Dascomb K, DeSilva M, et al.
MMWR Morb Mortal Wkly Rep
. 2024 Feb;
73(8):180-188.
PMID: 38421945
In September 2023, CDC's Advisory Committee on Immunization Practices recommended updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccination for all persons aged ≥6 months to prevent COVID-19, including severe disease. However, few...
13.
Lewis N, Zhu Y, Peltan I, Gaglani M, McNeal T, Ghamande S, et al.
Clin Infect Dis
. 2023 Dec;
78(4):1056-1064.
PMID: 38051664
Background: Influenza circulation during the 2022-2023 season in the United States largely returned to pre-coronavirus disease 2019 (COVID-19)-pandemic patterns and levels. Influenza A(H3N2) viruses were detected most frequently this season,...
14.
Surie D, Yuengling K, DeCuir J, Zhu Y, Gaglani M, Ginde A, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Oct;
72(40):1083-1088.
PMID: 37796753
On June 21, 2023, CDC's Advisory Committee on Immunization Practices recommended respiratory syncytial virus (RSV) vaccination for adults aged ≥60 years, offered to individual adults using shared clinical decision-making. Informed...
15.
Kojima N, Adams K, Self W, Gaglani M, McNeal T, Ghamande S, et al.
Clin Infect Dis
. 2023 May;
77(4):547-557.
PMID: 37255285
Introduction: Understanding the changing epidemiology of adults hospitalized with coronavirus disease 2019 (COVID-19) informs research priorities and public health policies. Methods: Among adults (≥18 years) hospitalized with laboratory-confirmed, acute COVID-19...
16.
DeCuir J, Surie D, Zhu Y, Gaglani M, Ginde A, Douin D, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Apr;
72(17):463-468.
PMID: 37104244
As of April 2023, the COVID-19 pandemic has resulted in 1.1 million deaths in the United States, with approximately 75% of deaths occurring among adults aged ≥65 years (1). Data...
17.
Gibbs K, Ginde A, Prekker M, Seitz K, Stempek S, Taylor C, et al.
medRxiv
. 2023 Mar;
PMID: 36993496
Background: Hypoxemia is a common and life-threatening complication during emergency tracheal intubation of critically ill adults. The administration of supplemental oxygen prior to the procedure ("preoxygenation") decreases the risk of...
18.
Dimcheff D, Blair C, Zhu Y, Chappell J, Gaglani M, McNeal T, et al.
J Infect Dis
. 2023 Mar;
228(3):235-244.
PMID: 36883903
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic and subgenomic RNA levels are frequently used as a correlate of infectiousness. The impact of host factors and SARS-CoV-2 lineage on...
19.
Klosko R, Arnold J, Murphy C, Brimmer J, Hagy N, Exline M, et al.
Int J Crit Illn Inj Sci
. 2023 Feb;
12(4):190-196.
PMID: 36779215
Background: Delirium occurs frequently in intensive care unit (ICU) patients; however, there are limited data evaluating its impact on critically ill hematology-oncology patients. We aimed to determine the incidence and...
20.
Lewis N, Murray N, Adams K, Surie D, Gaglani M, Ginde A, et al.
Open Forum Infect Dis
. 2023 Jan;
10(1):ofac698.
PMID: 36695662
Background: Coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) studies are increasingly reporting relative VE (rVE) comparing a primary series plus booster doses with a primary series only. Interpretation of rVE...